Soligenix (Warrant)
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SNGXW and buy or sell other stocks, options, and ETFs commission-free!About SNGXW
Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. It operates through the Specialized BioTherapeutics and Public Health Solutions segments.
CEOChristopher J. Schaber, PhD
CEOChristopher J. Schaber, PhD
Employees—
Employees—
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded1987
Founded1987
Employees—
Employees—
SNGXW Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high—
52 Week high—
52 Week low—
52 Week low—
SNGXW News
TipRanks 1d
Soligenix extends patent protection for Filovirus Vaccine platformSoligenix announced that it has received notice of intent to grant additional patents based on its patent application titled “Compositions and Methods of Manufa...
Yahoo Finance 1d
Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa - Yahoo FinanceIncludes thermostabilized Ebola vaccines MarVax™ and SuVax™ Includes nanoemulsion adjuvant compatible with lyophilization PRINCETON, N.J., April 25, 2024 /PRN...